Established in 2014, the company is a national high-tech enterprise specializing in R&D, production, sales and service of in vitro diagnostic products. It has strong technical research and innovation capabilities, and has strong technical strength in research in biological fields such as colloidal gold and latex labeling technology, monoclonal antibodies, polyclonal antibodies, recombinant antigens, synthetic antigens, etc., and immunochromatography technology. The company's main business is R&D, production and sales of in vitro rapid diagnostic reagents. The company's main products are POCT rapid diagnostic reagents. Corporate honors: Zhejiang Province's Top 500 High-tech Enterprises with Innovative Capabilities, China's Top 50 Medical Device Companies, Hangzhou Top 100 Manufacturing Enterprises, Hangzhou Digital Service Trade Top 100 Enterprises, China's First Batch of “1000 Enterprises, 100 Cities” Trademark Brand Value Enhancement Action Enterprises, Hangzhou Enterprise Technology Center, High-tech Enterprise, Hangzhou Enterprise High-tech R&D Center (industrial category), Hangzhou “three-star” headquarters enterprise, etc.